Author does a decent job of going through some things, but this statement did not sit well with me.
>I don’t think there are good data here, but my intuitions and personal experience is that “addiction” of the sort you get with heroin or tobacco is very rare, at least when responsible people without a personal or family history of addictive behavior take stimulants as prescribed. Most people agree the risk is lower for extended-release stimulants (eg Adderall XR), and very low for Vyvanse.
I think that statement is bonkers.
Of course they are going to be addicted to the substance if they use it everyday of their lives.
My definition of addiction is not being able to stop taking the drug for whatever reason, and feeling some sort of withdrawal. I think for most people that take something daily, it would be extremely hard for them to stop.
This is where things get messed up: being chemically addicted to something where the cost of the drug can be astronomical .Yes, I am talking about Shire's Vyvanse.
>Shire Plc is a Jersey-registered, Irish-headquartered global specialty biopharmaceutical company... its brands and products include Vyvanse, Lialda, and Adderall XR.
The best is that they offer a program the temporarily reduces the price of the drug for a period of time aka you get addicted to it over that time period and then are forced to pay it becuase their is nothing like it until 2023.
Yes, I am aware that each state has different insurance options, but starting a company called "Shire Cares" just to spread the belief that they care but really do not is silly.
From their website: "Pay no more than $30 for up to 12 prescriptions up to a maximum savings of $60 per prescription.† (https://www.shireregistration.com/vyvanse%20savings%20link)"
What they do not tell you is after that period ends, the price goes up drastically. With insurance, 30 pills costs "around $286.42 (https://www.goodrx.com/vyvanse)
The last thing I will say is: Where is the data on a drug that annually generates billions of dollars each year? They have 10 million users. You are telling me they could not monitor the habits of 1-2k people over a couple years? Sounds fishy to me.
For others who want to learn more about the crazy growth of add/adhd medication sales that very few want to talk about. (http://www.nytimes.com/2013/12/15/health/the-selling-of-atte...)